STOCK TITAN

Addus CEO Allison Exercises Options at $19.71, Sells Shares at ~$116

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

R. Dirk Allison, Chairman and CEO of Addus HomeCare (ADUS), reported multiple transactions on 09/02/2025. The filing shows acquisition of 25,000 shares via exercise of employee stock options at a $19.71 exercise price and two open-market disposals totaling 25,000 shares sold at weighted-average prices of $115.72 and $116.34. After these transactions the reporting person beneficially owned 166,461 shares directly. The filing notes all options are fully vested and provides weighted-average price ranges for the sales.

Positive

  • Exercise of fully vested options converts long-dated compensation into realized equity, showing retention of prior equity incentives
  • Substantial remaining ownership after transactions (166,461 shares) preserves continued alignment with shareholders

Negative

  • Insider sold 25,000 shares in open-market transactions at ~ $115–$116, which could be interpreted as partial liquidity-taking
  • No disclosure of a Rule 10b5-1 plan in the filing, so timing appears ad hoc rather than pre-arranged

Insights

TL;DR: CEO exercised vested options at low exercise price then sold shares at market prices; routine liquidity event by an insider.

The report documents a common insider sequence: exercise of fully vested employee stock options followed by sales of the underlying shares. Exercising 25,000 options at $19.71 and selling 25,000 shares at weighted-average prices around $116 indicates realization of long-term compensation value. The filing does not indicate use of a Rule 10b5-1 plan or other pre-arranged plan. Ownership after the transactions remains material at 166,461 shares.

TL;DR: Materiality to investors is limited absent additional context; transactions reflect personal liquidity rather than company performance statements.

The transactions are sizable in absolute terms but the filing provides no commentary tying the sales to company events or a predetermined trading plan. The data show conversion of equity compensation into cash at current market prices, which is a typical executive action and not, by itself, an operational signal. Investors would need holdings percentage or total outstanding share context to assess voting/ownership impact.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ALLISON R DIRK

(Last) (First) (Middle)
6303 COWBOYS WAY
SUITE 600

(Street)
FRISCO TX 75034

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman and CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 M 25,000 A $19.71 191,461 D
Common Stock 09/02/2025 S 20,565 D $115.72(1) 170,796 D
Common Stock 09/02/2025 S 4,435 D $116.34(2) 166,461 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $19.71 09/02/2025 M 25,000 (3) 01/21/2026 Common Stock 25,000 $0 0 D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.13 to $116.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.13 to $116.59, inclusive.
3. All options are fully vested.
/s/ Brian Poff, Attorney-in-Fact for R. Dirk Allison 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did ADUS insider R. Dirk Allison report on Form 4?

He exercised 25,000 employee stock options at an exercise price of $19.71 and sold a total of 25,000 shares in two sales at weighted-average prices of $115.72 and $116.34 on 09/02/2025.

How many shares does the reporting person own after these transactions?

166,461 shares were beneficially owned directly following the reported transactions.

Were the options exercised by the insider vested?

Yes; the filing states that all options are fully vested.

Did the Form 4 indicate the sales were made under a 10b5-1 trading plan?

No explicit indication of a Rule 10b5-1 plan or similar pre-arranged plan appears in the filing.

What were the weighted-average prices for the shares sold?

Weighted-average prices reported were $115.72 for 20,565 shares (range $115.13–$116.10) and $116.34 for 4,435 shares (range $116.13–$116.59).
Addus Homecare Corp

NASDAQ:ADUS

ADUS Rankings

ADUS Latest News

ADUS Latest SEC Filings

ADUS Stock Data

1.99B
18.00M
2.46%
104.29%
3.45%
Medical Care Facilities
Services-home Health Care Services
Link
United States
FRISCO